As of October 2024, Oncolytics Biotech has a market cap of $68.26M. This makes Oncolytics Biotech the world's 23422th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $83.67M | -15.56% |
2023 | $99.09M | -17.18% |
2022 | $119.64M | 17.27% |
2021 | $102.02M | -41.60% |
2020 | $174.69M | -50.00% |
2019 | $349.38M | 162.98% |
2018 | $132.85M | -66.57% |
2017 | $397.45M | 171.43% |
2016 | $146.43M | -22.22% |
2015 | $188.27M | -49.06% |
2014 | $369.56M | -65.81% |
2013 | $1.08B | -60.46% |
2012 | $2.73B | 0.51% |
2011 | $2.72B | -41.79% |
2010 | $4.67B | 156.70% |
2009 | $1.82B | 115.70% |
2008 | $843.72M | -29.65% |
2007 | $1.20B | -17.70% |
2006 | $1.46B | -55.15% |
2005 | $3.25B | 1.53% |
2004 | $3.20B | 33.43% |
2003 | $2.40B | 194.02% |
2002 | $815.83M | -72.21% |
2001 | $2.94B | - |